Suchergebnisse - (Subject:"PARP inhibitor")

PubPharm (138)

61

PARP Inhibitors Resistance: Mechanisms and Perspectives

in: Cancers | 2022

von Elena Giudice | Marica Gentile | Vanda Salutari | +10

62

Everything Comes with a Price: The Toxicity Profile of DNA-Damage Response Targeting Agents

in: Cancers | 2022

von Federica Martorana | Leandro Apolinario Da Silva | Cristiana Sessa | +1

63

IKKε Inhibitor Amlexanox Promotes Olaparib Sensitivity through the C/EBP-β-Mediated Transcription of Rad51 in Castrate-Resistant Prostate Cancer

in: Cancers | 2022

von Sophie Gilbert | Benjamin Péant | Anne-Marie Mes-Masson | +1

64

Glioblastoma Cells Counteract PARP Inhibition through Pro-Survival Induction of Lipid Droplets Synthesis and Utilization

in: Cancers | 2022

von Jara Majuelos-Melguizo | José Manuel Rodríguez-Vargas | Nuria Martínez-López | +7

65

PARP Inhibitors in Advanced Prostate Cancer in Tumors with DNA Damage Signatures

in: Cancers | 2022

von Ciara S. McNevin | Karen Cadoo | Anne-Marie Baird | +2

66

Pharmacologic Induction of BRCAness in

in: Cancers | 2022

von Rachel Abbotts | Anna J. Dellomo | Feyruz V. Rassool

67

BRCA Mutations in Ovarian and Prostate Cancer: Bench to Bedside

in: Cancers | 2022

von Stergios Boussios | Elie Rassy | Michele Moschetta | +6

68

Germline Aberrations in Pancreatic Cancer: Implications for Clinical Care

in: Cancers | 2022

von Raffaella Casolino | Vincenzo Corbo | Philip Beer | +5

69

Analysis of the Clinical Advancements for

in: Cancers | 2022

von Dylan P. McClurg | Gordan Urquhart | Trevor McGoldrick | +4

70

Attenuation of Muscle Damage, Structural Abnormalities, and Physical Activity in Respiratory and Limb Muscles following Treatment with Rucaparib in Lung Cancer Cachexia Mice

in: Cancers | 2022

von Maria Pérez-Peiró | Xavier Duran | José Yélamos | +1